Exclusive: Trial of Gilead’s potential coronavirus treatment running ahead of schedule, researcher says – Reuters
(Reuters) – A crucial U.S. federal government trial of Gilead Sciences Inc’s experimental coronavirus therapy may produce results as early as mid-May, according to the research’s lead investigator, after physicians shouted to register their patients in the study. SUBMIT PHOTO: An ampule of Ebola drug remdesivir is envisioned during a>>>